These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 34092643)

  • 1. The Burden of Alzheimer's Disease Mortality in the United States, 1999-2018.
    Zhao X; Li C; Ding G; Heng Y; Li A; Wang W; Hou H; Wen J; Zhang Y
    J Alzheimers Dis; 2021; 82(2):803-813. PubMed ID: 34092643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in Alzheimer's disease mortality from European vital statistics, 2012-2020.
    Zuin M; Brombo G; Polastri M; Romagnoli T; Cervellati C; Zuliani G
    Int J Geriatr Psychiatry; 2024 Mar; 39(3):e6068. PubMed ID: 38429957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deaths in the United States among persons with Alzheimer's disease (2010-2050).
    Weuve J; Hebert LE; Scherr PA; Evans DA
    Alzheimers Dement; 2014 Mar; 10(2):e40-6. PubMed ID: 24698031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality from Alzheimer's disease: an update.
    Hoyert DL; Rosenberg HM
    Natl Vital Stat Rep; 1999 Jun; 47(20):1-8. PubMed ID: 10459279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer disease burden decreased in the United States from 1975 to 2018: A joinpoint and age-period-cohort analysis.
    He J; Hu Q
    Medicine (Baltimore); 2023 Dec; 102(48):e36029. PubMed ID: 38050303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of early-onset colorectal cancer mortality rates in the United States using machine learning.
    Ali H; Patel P; Dahiya DS; Gangwani MK; Basuli D; Mohan BP
    Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38149332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time trends in Alzheimer's disease mortality attributable to metabolic risks and smoking in China from 1990 to 2019: an age-period-cohort analysis.
    Sun S; Zhang T; Yu H; Xia T; Yao Y; Sun M; Liang H; Huang Q; Wang W; Yang H; Hong X
    Front Aging Neurosci; 2024; 16():1425577. PubMed ID: 39026988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Cancer Protective for Subsequent Alzheimer's Disease Risk? Evidence From the Utah Population Database.
    Hanson HA; Horn KP; Rasmussen KM; Hoffman JM; Smith KR
    J Gerontol B Psychol Sci Soc Sci; 2017 Oct; 72(6):1032-1043. PubMed ID: 27101831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic variation in Alzheimer's disease mortality.
    Topping M; Kim J; Fletcher J
    PLoS One; 2021; 16(7):e0254174. PubMed ID: 34197566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality Trends in Alzheimer's Disease in Mississippi, 2011-2021.
    Jones EAK; Jenkins B; Addison C
    Diseases; 2023 Dec; 11(4):. PubMed ID: 38131985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous trends of premature mortalities in Japan: joinpoint regression analysis of years of life lost from 2011 to 2019.
    Tsuboi S; Mine T; Fukushima T
    Dialogues Health; 2022 Dec; 1():100071. PubMed ID: 38515924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database.
    Minhas AMK; Gupta K; Jain V; Kakar TS; Merchant AT; Shapiro MD; Abushamat LA; Nambi V; Virani SS
    Eur J Prev Cardiol; 2024 Mar; 31(5):e33-e35. PubMed ID: 37619975
    [No Abstract]   [Full Text] [Related]  

  • 13. How Bayesian statistics may help answer some of the controversial questions in clinical research on Alzheimer's disease.
    Temp AGM; Lutz MW; Trepel D; Tang Y; Wagenmakers EJ; Khachaturian AS; Teipel S
    Alzheimers Dement; 2021 Jun; 17(6):917-919. PubMed ID: 34115436
    [No Abstract]   [Full Text] [Related]  

  • 14. Soluble Amyloid-β Consumption in Alzheimer's Disease.
    Espay AJ; Sturchio A; Schneider LS; Ezzat K
    J Alzheimers Dis; 2021; 82(4):1403-1415. PubMed ID: 34151810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of high-risk pedigrees identifies 11 candidate variants for Alzheimer's disease.
    Teerlink CC; Miller JB; Vance EL; Staley LA; Stevens J; Tavana JP; Cloward ME; Page ML; Dayton L; ; Cannon-Albright LA; Kauwe JSK
    Alzheimers Dement; 2022 Feb; 18(2):307-317. PubMed ID: 34151536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotrophic signaling deficiency exacerbates environmental risks for Alzheimer's disease pathogenesis.
    Wu Z; Chen C; Kang SS; Liu X; Gu X; Yu SP; Keene CD; Cheng L; Ye K
    Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34140411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Schumacher J; Gunter JL; Przybelski SA; Jones DT; Graff-Radford J; Savica R; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Knopman DS; Fields JA; Kremers WK; Petersen RC; Graff-Radford NR; Ferman TJ; Boeve BF; Thomas AJ; Taylor JP; Kantarci K
    Brain; 2021 Nov; 144(10):3212-3225. PubMed ID: 34114602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's drug approved despite murky results.
    Servick K
    Science; 2021 Jun; 372(6547):1141. PubMed ID: 34112676
    [No Abstract]   [Full Text] [Related]  

  • 19. Unraveling the heterogeneity in Alzheimer's disease progression across multiple cohorts and the implications for data-driven disease modeling.
    Birkenbihl C; Salimi Y; Fröhlich H; ;
    Alzheimers Dement; 2022 Feb; 18(2):251-261. PubMed ID: 34109729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily briefing: Alzheimer's drug controversially approved by FDA.
    Graham F
    Nature; 2021 Jun; ():. PubMed ID: 34108728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.